Results 201 to 210 of about 16,319,187 (298)

State-Level Impacts of Key Medicaid Provisions in the One Big Beautiful Bill Act.

Rand Health Q
Rao P, Baker L, Girosi F, Li E, Kerber R, Eibner C.   +5 more
europepmc   +1 more source

Brain-inspired cognitive state modeling of complex English discourse reading: an LLM-parameterized hierarchical semi-Markov approach. [PDF]

Front Neurorobot
Xie B, Hu Y, Zhao L.
europepmc   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Neural state reduction: a quantum-inspired framework for how latent conscious thought becomes reportable. [PDF]

Front Comput Neurosci
Pradeep AK.
europepmc   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

Molecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis, Jack V. Mills, Wojciech Niedzwiedz, Valentine M. Macaulay   +3 more
wiley   +1 more source

Prevalence of inflammatory bowel disease across states: estimates based on claims database. [PDF]

Inflamm Bowel Dis
Kang H, Karlin KL, Brensinger CM, Ehrlich OG, Kappelman MD, Moss A, Lewis JD.   +6 more
europepmc   +1 more source